IMV INC

YTD

ALL

Why Robinhood?

You can watch IMV INC and buy or sell other stocks, ETFs, and their options commission-free!

About IMVIF

IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response.

CEO

Andrew Hall

CEOAndrew Hall

Employees

—

Employees—

Headquarters

Dartmouth, Nova Scotia

HeadquartersDartmouth, Nova Scotia

Founded

2007

Founded2007

Employees

—

Employees—

IMVIF Key Statistics

Market cap

3.51K

Market cap3.51K

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

143.90

Average volume143.90

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.0003

52 Week high$0.0003

52 Week low

$0.00

52 Week low$0.00

People also own

Based on the portfolios of people who own IMVIF. This list is generated using Robinhood data, and it’s not a recommendation.